Fig. 2

Pharmacist-reported (a, b) and student-reported (c, d) rankings for importance of outcomes (a, c) and approaches (b, d) with regard to OUD treatment and management. The dotted line on the figures indicates the midpoint of the scale. ANOVA w Tukey’s Correction: **p < 0.01 vs. overdose prevention; ***p < 0.001 vs. overdose prevention; ****p < 0.0001 vs. overdose prevention; ^#p < 0.05 vs. decreased reward; ^{^}p < 0.05 vs. treatment access; ^{^^^}p < 0.001 vs. treatment access; ⁺⁺⁺p < 0.001 vs. new treatments; ⁺⁺⁺⁺p < 0.0001 vs. new treatments